SlideShare a Scribd company logo
1 of 9
Download to read offline
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 1
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Outcome of Screening Test Performed on
Volunteer Blood Donors in Chittagong City
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012
Jashim MU1
, Sanjoy KD2
, Suhrawardy SM3
, Moynal H4
, Pranab C5
Abstract— Introduction: In Bangladesh every year about 270,000 units of blood need for transfusion. To meet such a big amount blood
transfusion needs huge numbers of donors. According to WHO estimate, in Bangladesh every year found up to 16 million new infection with
HBV, 5 million new infection with HCV and 160,000 new cases of HIV infection of effective screening of blood donors. This study aimed to
determine the prevalence of infectious diseases among the Chittagong city, Bangladesh.
Methods: This was a cross sectional study among 1500 volunteer blood donors in the Chittagong city from January, 2011 to September, 2011.
Each donor was screened for Hepatitis B Virus, Hepatitis C virus, HIV, Malaria & Syphilis with Latex agglutination, immunochromatographic
(ICT) test strip supplied by reagent manufacturer.
Results: A total of 1500 volunteer blood donors with different age group and occupations volunteer participated in the study. 1320 were male
and 180 were female with on professional blood donor. There are found total 33 positive cases in screening test of which HBsAg positive 21
cases (1.40%), anti-HIV positive 02 cases (0.13%), anti-HCV positive 02 cases (0.13%), RPR positive 07 cases (0.46%), Malaria positive 01
case (0.06%).
Conclusion: This study proof that many apparently healthy blood donors are not safe donor, so screening test before blood or component of
blood transfusion should be mandatory even for volunteer blood donor.
Index Terms— Blood Donors, WHO, Bangladesh, Chittagong, Blood Transfusion, HIV, HBV, HCV, MP, RPR.
——————————  ——————————
1. Md. Jashim Uddin, Assistant Professor & HOD Department of Pathology, BGC Trust Medical College.
2. Sanjoy Kumar Dey, Assistant Professor Department of Neonatology, BSMMU, Shahbag, Dhaka.
3. S. M. Suhrawardy, Assistant Professor Department of Physiology, BGC Trust Medical College.
4. Moynal Hossain, Assistant Professor Department of Community Medicine, BGC Trust Medical College.
5. Pranab Chowdhury, Senior Lecturer Department of Pathology, BGC Trust Medical College.
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 2
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Outcome of Screening
Test Performed on
Volunteer Blood
Donors in Chittagong
City
International Journal of Scientific & Engineering Research Volume
3, Issue 12, December-2012
1. To find out percentages of volunteer blood donors
infected with Hepatitis B Virus, Hepatitis C virus, HIV,
Malaria & syphilis.
2. To find out relation of the volunteer blood donors infected
with infectious diseases with occupation.
3. To explore percentages of Male & Female among the
different screening test positive volunteer blood donors.
4. To identify percentage of different age group among the
volunteer blood donors infected with infectious diseases.
INTRODUCTION
Blood transfusion history dates back about 200
years and is relatively recent considering the history of
mankind. The credit of first successful human to human
blood transfusion goes Dr. James Blundell, an obstetrician,
who successfully transfused 8 oz (227 ml) of blood to a
patient of post partum haemorrhage in 1818.2
The practice of Modern blood transfusion began
in early twentieth century, about a hundred years back, with
the discovery of the ABO blood group antibodies and
antigens by Nobel Prize winner Karl Landsteiner, an
Austrian physician in 1901 and Rh blood group antigens by
Landsteiner and wiener in 1940. 2
According to WHO estimate the lack of effective
screening of blood donor's results in up to 16 million new
infections with HBV, 5 million new infections with HCV and
160,000 new cases of HIV infection every year. Incidences of
transfusion mediated falciparum infected found in
Bangladesh. 2
For many years WHO has been working to help
nation to make the transfusion safe with following
guidelines2:
a. Establishment of a nationally coordinated blood
transfusion service.
b. Collection of blood only from voluntary donors.
c. Testing of all blood for compatibility and TTIs
and reduction of unnecessary transfusion.
In Bangladesh every year about 270,000 units of
blood need for transfusion. To meet such a big amount
blood transfusion needs huge numbers of donors.
Unfortunately it has been found that in this country
professional blood donors are providing majority of the
units of blood annually. A total of 1,687,390 donations under
safe blood transfusion program mainly from voluntary
donors were screened throughout the country during a
period of 8 years (2001-2008). One hundred eleven donors
(0.0065%) were found to be Positive for HIV. Overall
HBsAg, anti-HCV and RPR was found positive in 0.96%,
0.15% and 0.15% donation respectively.2
So considering all above discussion it is found
very important to screen all blood donations both voluntary
and professional to prevent transfusion Mediated infectious
diseases.
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 3
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
METHODS & MATERIALS
Method: -
 Types of study- Descriptive cross sectional study.
 Place of study- Chittagong City.
 Period of study- January, 2011 to September, 2011.
 Sample size/number of cases- 1500.
Research Materials: -
 Blood sample collected in pre-labeled pilot tubes,
serum separated from clotted blood.
 Sterile disposable plastic syringe.
 Latex agglutination immunochromatographic (ICT)
test strip to detect-
 HBsAg
 Anti- HCV
 Anti- HIV
 Anti treponema
 Malaria
 Leishman stained, Geimsa stained thin & thick
blood film study for Malaria parasite.
 Procedure of test- Tests performed according
instruction supplied by reagent manufacturer.
RESULTS
Results are shown in the following diagrams and tables.
Figure 1: Distribution of volunteer blood donors by sex
Figure 2: Distribution of volunteer blood donors by age
88%
12%
Distribution of volunteer blood donors
by sex (n=1500)
Male= 1320. Female= 180.
82
395
413
284
180
97
33
6 10
0
50
100
150
200
250
300
350
400
450
15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55+
Distribution of volunteer blood donors by age (n=1500)
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 4
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Figure 3: Distribution of blood donor according to occupation
Figure 4: Percentage of disease among the total positive cases
0
100
200
300
400
500
600
Ser. Holder Student Housewife Business Driver Others
Distribution of blood donor according to occupation (n=1500)
37.54%
18.33%
6.00%
31.20%
2.13%
4.80%
563 275 90 468 32 72
HBsAg(21)
63.64%
HIV(02)
6.06%
RPR(07)
21.21%
HCV(02)
6.06%
MP(01)
3.03%
Percentage of disease among the total positive cases (n=33)
HBsAg(21)
HIV(02)
RPR(07)
HCV(02)
MP(01)
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 5
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Table 1: Distribution of volunteer blood donors by HBsAg
Status
Status of
HBsAg
Number Percentage
Positive 21 1.40 %
Negative 1479 98.60 %
Total 1500 100 %
Table 2: Distribution of volunteer blood donors by HIV
Status
Status of HIV Number Percentage
Positive 02 0.13 %
Negative 1498 99.87 %
Total 1500 100 %
Table 3: Distribution of volunteer blood donors by HCV
Status
Status of HCV Number Percentage
Positive 02 0.13 %
Negative 1498 99.87 %
Total 1500 100 %
Table 4: Distribution of volunteer blood donors by RPR
Status
Status of RPR Number Percentage
Positive 07 0.46 %
Negative 1493 99.54 %
Total 1500 100 %
Table 5: Distribution of volunteer blood donors by MP
Status
Status of MP Number Percentage
Positive 01 0.06 %
Negative 1499 99.94 %
Total 1500 100 %
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 6
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Table 6: Disease by Occupation (%)
Occupation HBsAg HIV HCV RPR MP
Service Holder 7 50/33.33 1 7.14/50 1 7.14/50 4 28.58/57.14 1 7.14/100 14 (100%)
Student 4 100/19.05 0 0 0 0 4 (100%)
Housewife 0 0 0 0 0 0 (100%)
Business 8 72.73/38.10 0 1 9.09/50 2 18.18/28.57 0 11 (100%)
Driver 2 66.66/9.52 0 0 1 33.34/14.29 0 3 (100%)
Others 0 1 100/50 0 0 0 1 (100%)
Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%)
Table 7: Disease by Age (%)
Age in year HBsAg HIV HCV RPR MP
15 - 19 1 100/4.77 0 0 0 0 1 (100%)
20 - 24 6 85.71/28.56 0 0 1 14.29/14.29 0 7 (100%)
25 - 29 9 81.82/42.85 0 1 9.09/50 0 1 9.09/100 11 (100%)
30 - 34 4 40/19.05 2 20/100 0 4 40/57.14 0 10 (100%)
35 - 39 1 50/4.77 0 1 50/50 0 0 2 (100%)
40 - 44 0 0 0 2 100/28.57 0 2 (100%)
45 - 49 0 0 0 0 0 0 (100%)
50 - 54 0 0 0 0 0 0 (100%)
55+ 0 0 0 0 0 0 (100%)
Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%)
Table 8: Disease by Sex (%)
Sex HBsAg HIV HCV RPR MP
Male 20 62.5/95.25 2 6.25/100 2 6.25/100 7 21.87/100 1 3.13/100 32 (100%)
Female 01 100/4.75 0 0 0 0 1 (100%)
Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%)
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 7
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
Table 9: Disease by Blood Group (%)
Blood Group HBsAg HIV HCV RPR MP
A+ 6 75/28.57 0 0 1 12.5/14.29 1 12.5/100 8 (100%)
B+ 7 53.85/33.33 1 7.69/50 1 7.69/50 4 30.77/57.14 0 13 (100%)
AB+ 4 80/19.05 0 1 20/50 0 0 5 (100%)
O+ 4 57.14/19.05 1 14.29/50 0 2 28.57/28.57 0 7 (100%)
A- 0 0 0 0 0 0 (100%)
B- 0 0 0 0 0 0 (100%)
AB- 0 0 0 0 0 0 (100%)
O- 0 0 0 0 0 0 (100%)
Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%)
DISCUSSION
In this study, total numbers of donors are 1500
among which there was no professional donor. Among them
HBsAg positive was 21 cases (1.40%), anti-HIV positive
02cases (0.13%), anti-HCV positive 02 cases (0.13%), RPR
(TP) positive 07 cases (0.46%), Malaria positive 01 case
(0.06%).
In a "Study on screening tests among the blood
donors in Dhaka Medical College Hospital, Bangladesh" 1
done from January to December 2009 where out of 21,448
donors HBsAg positive were 297 (1.38%), anti-HCV positive
38 (0.10%), RPR (TP) positive 09 (0.40%), MP positive 23
(0.11%), 1 which are almost near to this study.
In a another study "Incidence of common
transfusion transmitted diseases among blood donors" 7
done in Khulna Medical College Hospital (KMCH) on 12,270
voluntary and directed donors during the period from 1st
July 2007 to 30th June 2008 to see the incidence of HBV, HIV,
HCV, Syphilis & MP, where it shows HBsAg positive were
171 (1.39%), anti-HIV positive 01 (0.008%), anti-HCV
positive 03 (0.024%), none found positive for RPR (TP) and
Malaria. 7
In our study found HBsAg positive were 21 cases
(1.40%), anti-HIV positive 02 cases (0.13%), anti-HCV
positive 02 cases (0.13%), RPR (TP) positive 07 cases (0.46%),
Malaria positive 01 case (0.06%). Compare to this study
Khulna Medical College Hospital (KMCH) study shows less
numbers of HIV positive, no positive cases of RPR (TP) and
Malaria. Probably because of geographical different,
professional different as of Chittagong are more overseas
worker & Chittagong is a Malaria zone too, period of study
and prevalence of unsafe sex & I.V. drug abusers should
consider because all those are increasing now a days.
One study in Nigeria "Sexual transmission of
the hepatitis B virus among blood donors in a tertiary
hospital in Nigeria" 9 done are 234 blood donors aged 18 to
56 years (mean 27.3 years) shows 40 (17.1%) participants
found positive and 194 (82.9%) negative for HBsAg. 9
In our study it is found only 21 (1.40%) cases
positive for HBsAg among 1500 cases. This big different of
HBsAg positive probably because of religious conservations,
more safe sex and less I.V. drug abusers in Bangladesh.
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 8
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
One study in Philippines "The prevalence of
HBsAg(+) and anti-HCV(+) among healthy blood donors
at EAMC, Quezon City" 6 done in 6,560 healthy blood
donors from December 1, 2003 to November 30, 2004 at East
Avenue Medical Center among which 503 (7.67%) donors
are HBsAg positive. There were only 07 (0.12%) donors who
tested positive for anti-HCV among 6,057 cases of the
donors.6 & another in Turkey "The prevalence of HBV,
HCV and HIV infection among donor in Ijmer, Turkey" 5
HBV positive (1.38%) and HCV positive (0.35%).5
In our study HBsAg positive was 21 cases (1.40%)
& anti-HCV positive 02 cases (0.13%).In a study in Canada
"Incidence of HBV, HCV and HIV in Canada" 4 which were
HBsAg positive is (12.40%), HIV positive (0.38%) and HCV
positive (16.83%). 4
In our study, HBsAg positive was 21 cases
(1.40%), anti-HIV positive 02 cases (0.13%) & anti-HCV
positive 02 cases (0.13%).
In Bombay, HBsAg positive in 06% and in
Pakistan it is 05%. 3
In our study, HBsAg positive was 1.40%.
In another study done by "Safe blood transfusion
center, Annual reports of donor screening, DMCH,
Dhaka"8 in 2009 which were HBsAg positive (0.96%), HIV
positive (0.0065%), HCV positive (0.15%) & RPR (TP)
positive (0.15%). 8
In our study HBsAg positive was (1.40%), anti-
HIV positive (0.13%), anti-HCV (0.13%), RPR (TP) positive
(0.46%).
CONCLUSION
In this study it has been found that out of 1500
volunteer blood donors 33 persons are screening positive
who are apparently healthy but they don’t has any
knowledge that they are infected by these sort of
transmissible infective dangerous disease which can cause
1. Serious complication to the affected individuals
as they would not seek medical care as long as
they remain asymptomatic.
2. Easy transmission to other healthy people
because of lacking of preventive measure
because the affected individuals and his
surrounding peoples, family members are not
aware about the condition.
This study proof that many apparently healthy
blood donors are not safe donor, so screening test before
blood or component of blood transfusion should be
mandatory even for volunteer blood donor.
SUGGESTION
Increasing level of consciousness about
transmission of transmissible disease by counseling about
blood & blood component transfusion, multiple uses of
needles, safe sex etc.
Assuring use of sterile surgical instruments,
syringe, using gloves by medical staff.
Government, NGO should come forward make
the screening test available & chipper.
International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 9
ISSN 2229-5518
IJSER © 2012
http://www.ijser.org
ACKNOWLEDGEMENT
Special thanks to "Sheik Md. Morshedul Alam Chy"
Technologist (Agrani Pathology Laboratory, Banadrtila,
Chittagong-4218, Bangladesh) for his cordial help for the
study.
REFERENCES
1. Chowdhury FS, Begum HA, Adnan SD, Hoque MM, Hossain MZ,
Siddiqui MAE, et al. Study on screening tests among the blood donors in
DMCH, Bangladesh. J Dhaka Medcoll. 2010; 19(1): 16-18.
2. Mahmud Z, et al. Are the blood transfusions safe! JAFMC Bangladesh.
Vol 5, No 1 (June) 2009.
3. Rahman K, Khan AA, Huda Z, et al. Prevalence of seromarkers of HBV
and HCV in health care personal and apparently healthy blood donors. J
Pak Med Assoc. 46: 152-4.
4. Chiavetta JA, Escobar M, et al. Incidence of HBV, HCV and HIV in
Canada, CMAJ. 2003; 169(8).
5. The prevalence of HBV, HCV and HIV infection among donor in Ijmer,
Turkey. Indian J Med Microbiol. 26(3).
6. John G Rodenas, Laura C Bacasen, Ernesto R Que, et al. The prevalence
of HBsAg(+) and anti-HCV(+) among healthy blood donors at EAMC,
Quezon City. Phil J of Gastroenterology 2006; 2:64:70.
7. Ahmed MU, Begum HA, Hossain T, Chakraborty P, et al. Incidence of
common transfusion transmitted diseases among blood donors. JAFMC
Bangladesh. Vol 5, No 1 (June) 2009.
8. Safe blood transfusion center. Annual reports of donor screening,
DMCH, Dhaka. 2009.
9. Adekanle O, Ndububa DA, Ayodeji OO, Paul-Odo B, Folorunso TA, et
al. Sexual transmission of the hepatitis B virus among blood donors in a
tertiary hospital in Nigeria. Singapore Med J 2010; 51(12): 944.

More Related Content

What's hot

All cause mortality in treated hiv-infected
All cause mortality in treated hiv-infectedAll cause mortality in treated hiv-infected
All cause mortality in treated hiv-infectedAna Paula Bringel
 
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 PatientsPCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 PatientsValentina Corona
 
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...hivlifeinfo
 
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...hivlifeinfo
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019hivlifeinfo
 
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...Contemporary Management of HIV.How Common Comorbidities Affect ART Management...
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...hivlifeinfo
 
Confronting the Challenges of HIV Care in an Aging Population.2019
Confronting the Challenges of HIV Care in an Aging Population.2019Confronting the Challenges of HIV Care in an Aging Population.2019
Confronting the Challenges of HIV Care in an Aging Population.2019hivlifeinfo
 
What’s New in Coformulated Antiretroviral Regimens.2014
What’s New in Coformulated Antiretroviral Regimens.2014What’s New in Coformulated Antiretroviral Regimens.2014
What’s New in Coformulated Antiretroviral Regimens.2014Hivlife Info
 
Upsurge of chikungunya cases in Uttar Pradesh, India
Upsurge of chikungunya cases in Uttar Pradesh, IndiaUpsurge of chikungunya cases in Uttar Pradesh, India
Upsurge of chikungunya cases in Uttar Pradesh, IndiaAhmad Ozair
 
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...hivlifeinfo
 
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...Ahmad Ozair
 
Современное лечение ВИЧ: индивидуализация стартовой АРТ /Contemporary Manage...
Современное лечение ВИЧ:  индивидуализация стартовой АРТ /Contemporary Manage...Современное лечение ВИЧ:  индивидуализация стартовой АРТ /Contemporary Manage...
Современное лечение ВИЧ: индивидуализация стартовой АРТ /Contemporary Manage...hivlifeinfo
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlJAFAR ALSAID
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, IntroductionCornelia Adlhoch
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19JAFAR ALSAID
 
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...hivlifeinfo
 
Determining Candidacy and Strategies for ART Modification.2019
Determining Candidacy and Strategies for ART Modification.2019Determining Candidacy and Strategies for ART Modification.2019
Determining Candidacy and Strategies for ART Modification.2019hivlifeinfo
 
Estimates of the severity of coronavirus disease 2019 - a model-based analysis
Estimates of the severity of coronavirus disease 2019 - a model-based analysisEstimates of the severity of coronavirus disease 2019 - a model-based analysis
Estimates of the severity of coronavirus disease 2019 - a model-based analysisGuy Boulianne
 

What's hot (19)

All cause mortality in treated hiv-infected
All cause mortality in treated hiv-infectedAll cause mortality in treated hiv-infected
All cause mortality in treated hiv-infected
 
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 PatientsPCR Assay Turned Positive in 25 Discharged COVID-19 Patients
PCR Assay Turned Positive in 25 Discharged COVID-19 Patients
 
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...
Ключевые решения в лечении ВИЧ: оптимизация стратегии лечения для пациентов с...
 
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
Современное лечение ВИЧ: лечение многократно леченных пациентов с резистентно...
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019
 
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...Contemporary Management of HIV.How Common Comorbidities Affect ART Management...
Contemporary Management of HIV.How Common Comorbidities Affect ART Management...
 
Confronting the Challenges of HIV Care in an Aging Population.2019
Confronting the Challenges of HIV Care in an Aging Population.2019Confronting the Challenges of HIV Care in an Aging Population.2019
Confronting the Challenges of HIV Care in an Aging Population.2019
 
What’s New in Coformulated Antiretroviral Regimens.2014
What’s New in Coformulated Antiretroviral Regimens.2014What’s New in Coformulated Antiretroviral Regimens.2014
What’s New in Coformulated Antiretroviral Regimens.2014
 
Upsurge of chikungunya cases in Uttar Pradesh, India
Upsurge of chikungunya cases in Uttar Pradesh, IndiaUpsurge of chikungunya cases in Uttar Pradesh, India
Upsurge of chikungunya cases in Uttar Pradesh, India
 
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...
Ключевые слайды по индивидуальному выбору АРТ / Key Slides on Individualized ...
 
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...
Scrub typhus manifesting with intracerebral hemorrhage: Case report and revie...
 
Современное лечение ВИЧ: индивидуализация стартовой АРТ /Contemporary Manage...
Современное лечение ВИЧ:  индивидуализация стартовой АРТ /Contemporary Manage...Современное лечение ВИЧ:  индивидуализация стартовой АРТ /Contemporary Manage...
Современное лечение ВИЧ: индивидуализация стартовой АРТ /Contemporary Manage...
 
179th publication jfmpc- 7th name
179th publication  jfmpc- 7th name179th publication  jfmpc- 7th name
179th publication jfmpc- 7th name
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection control
 
1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction1st Hepatitis E virus expert meeting at ECDC, Introduction
1st Hepatitis E virus expert meeting at ECDC, Introduction
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19
 
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
 
Determining Candidacy and Strategies for ART Modification.2019
Determining Candidacy and Strategies for ART Modification.2019Determining Candidacy and Strategies for ART Modification.2019
Determining Candidacy and Strategies for ART Modification.2019
 
Estimates of the severity of coronavirus disease 2019 - a model-based analysis
Estimates of the severity of coronavirus disease 2019 - a model-based analysisEstimates of the severity of coronavirus disease 2019 - a model-based analysis
Estimates of the severity of coronavirus disease 2019 - a model-based analysis
 

Viewers also liked

How to triple your content marketing results
How to triple your content marketing resultsHow to triple your content marketing results
How to triple your content marketing resultsBryan Fleming
 
Social media content creation made easy
Social media content creation made easySocial media content creation made easy
Social media content creation made easyBryan Fleming
 
4 content creation tricks that help avoid writer's block forever
4 content creation tricks that help avoid writer's block forever4 content creation tricks that help avoid writer's block forever
4 content creation tricks that help avoid writer's block foreverBryan Fleming
 
The biggest social media marketing mistake
The biggest social media marketing mistakeThe biggest social media marketing mistake
The biggest social media marketing mistakeBryan Fleming
 
How to easily get 94% more social media engagement, shares, and likes
How to easily get 94% more social media engagement, shares, and likesHow to easily get 94% more social media engagement, shares, and likes
How to easily get 94% more social media engagement, shares, and likesBryan Fleming
 
Facebook Ads Case Study Email List Building For Businesses Part 3
Facebook Ads Case Study Email List Building For Businesses Part 3Facebook Ads Case Study Email List Building For Businesses Part 3
Facebook Ads Case Study Email List Building For Businesses Part 3Bryan Fleming
 
3 biggest facebook advertising mistakes - facebook advertising tips and stra...
3 biggest facebook advertising mistakes -  facebook advertising tips and stra...3 biggest facebook advertising mistakes -  facebook advertising tips and stra...
3 biggest facebook advertising mistakes - facebook advertising tips and stra...Bryan Fleming
 
Faceboook Ads Case Study List Building For Businesses Part 2
Faceboook Ads Case Study List Building For Businesses Part 2Faceboook Ads Case Study List Building For Businesses Part 2
Faceboook Ads Case Study List Building For Businesses Part 2Bryan Fleming
 
Facebook For Business Tutorial 2015
Facebook For Business Tutorial 2015Facebook For Business Tutorial 2015
Facebook For Business Tutorial 2015Bryan Fleming
 
Facebook Advertising For Business Email Lead Generation
Facebook Advertising For Business Email Lead GenerationFacebook Advertising For Business Email Lead Generation
Facebook Advertising For Business Email Lead GenerationBryan Fleming
 

Viewers also liked (12)

How to triple your content marketing results
How to triple your content marketing resultsHow to triple your content marketing results
How to triple your content marketing results
 
Finalversion_SRC2013_LEFrankel
Finalversion_SRC2013_LEFrankelFinalversion_SRC2013_LEFrankel
Finalversion_SRC2013_LEFrankel
 
Social media content creation made easy
Social media content creation made easySocial media content creation made easy
Social media content creation made easy
 
4 content creation tricks that help avoid writer's block forever
4 content creation tricks that help avoid writer's block forever4 content creation tricks that help avoid writer's block forever
4 content creation tricks that help avoid writer's block forever
 
The biggest social media marketing mistake
The biggest social media marketing mistakeThe biggest social media marketing mistake
The biggest social media marketing mistake
 
How to easily get 94% more social media engagement, shares, and likes
How to easily get 94% more social media engagement, shares, and likesHow to easily get 94% more social media engagement, shares, and likes
How to easily get 94% more social media engagement, shares, and likes
 
Facebook Ads Case Study Email List Building For Businesses Part 3
Facebook Ads Case Study Email List Building For Businesses Part 3Facebook Ads Case Study Email List Building For Businesses Part 3
Facebook Ads Case Study Email List Building For Businesses Part 3
 
3 biggest facebook advertising mistakes - facebook advertising tips and stra...
3 biggest facebook advertising mistakes -  facebook advertising tips and stra...3 biggest facebook advertising mistakes -  facebook advertising tips and stra...
3 biggest facebook advertising mistakes - facebook advertising tips and stra...
 
Facebook ad testing
Facebook ad testingFacebook ad testing
Facebook ad testing
 
Faceboook Ads Case Study List Building For Businesses Part 2
Faceboook Ads Case Study List Building For Businesses Part 2Faceboook Ads Case Study List Building For Businesses Part 2
Faceboook Ads Case Study List Building For Businesses Part 2
 
Facebook For Business Tutorial 2015
Facebook For Business Tutorial 2015Facebook For Business Tutorial 2015
Facebook For Business Tutorial 2015
 
Facebook Advertising For Business Email Lead Generation
Facebook Advertising For Business Email Lead GenerationFacebook Advertising For Business Email Lead Generation
Facebook Advertising For Business Email Lead Generation
 

Similar to Outcome-of-Screening-Test-Performed-on-Volunteer-Blood-Donors-in-Chittagong-City

Testing Donor For Anti HbcIgM to Enhance Blood Safety
Testing Donor For Anti HbcIgM to Enhance Blood SafetyTesting Donor For Anti HbcIgM to Enhance Blood Safety
Testing Donor For Anti HbcIgM to Enhance Blood Safetyiosrjce
 
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...IOSRJPBS
 
Blood safety issues 2018
Blood safety issues 2018Blood safety issues 2018
Blood safety issues 2018Albert Farrugia
 
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...Red cell alloimmunization in blood transfusion dependent Patients with Sickle...
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...iosrjce
 
Detection of hepatitis b surface antigen (hbs ag) and hepatitis c
Detection of hepatitis b surface antigen (hbs ag) and hepatitis cDetection of hepatitis b surface antigen (hbs ag) and hepatitis c
Detection of hepatitis b surface antigen (hbs ag) and hepatitis cAlexander Decker
 
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...IjcmsdrJournal
 
study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...RahulGupta1687
 
Hep b & c in blood donors
Hep b & c in blood donorsHep b & c in blood donors
Hep b & c in blood donorsRashmi Sd
 
atypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxatypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxDrSrinivasJayanthur
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center UC San Diego AntiViral Research Center
 
Seroprevalence of HBV infection
Seroprevalence of HBV infectionSeroprevalence of HBV infection
Seroprevalence of HBV infectionAdnan Ahmad
 
The relationship between the molecular epidemiology of hepatitis c and the be...
The relationship between the molecular epidemiology of hepatitis c and the be...The relationship between the molecular epidemiology of hepatitis c and the be...
The relationship between the molecular epidemiology of hepatitis c and the be...Alexander Decker
 
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...PUBLISHERJOURNAL
 
CONFERENCE PROCEEDINGS(B3SC),September 2016,London
CONFERENCE PROCEEDINGS(B3SC),September 2016,LondonCONFERENCE PROCEEDINGS(B3SC),September 2016,London
CONFERENCE PROCEEDINGS(B3SC),September 2016,LondonGlobal R & D Services
 

Similar to Outcome-of-Screening-Test-Performed-on-Volunteer-Blood-Donors-in-Chittagong-City (20)

Testing Donor For Anti HbcIgM to Enhance Blood Safety
Testing Donor For Anti HbcIgM to Enhance Blood SafetyTesting Donor For Anti HbcIgM to Enhance Blood Safety
Testing Donor For Anti HbcIgM to Enhance Blood Safety
 
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...
Study of Some Serological Markers (Hbs Ag, Anti-Hbs and AntHbc Igm) for Detec...
 
Blood safety issues 2018
Blood safety issues 2018Blood safety issues 2018
Blood safety issues 2018
 
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...Red cell alloimmunization in blood transfusion dependent Patients with Sickle...
Red cell alloimmunization in blood transfusion dependent Patients with Sickle...
 
SEROPREVALENCE OF HEPATITIS C VIRUS AMONG INDOOR AND OUTDOOR PATIENTS OF A TE...
SEROPREVALENCE OF HEPATITIS C VIRUS AMONG INDOOR AND OUTDOOR PATIENTS OF A TE...SEROPREVALENCE OF HEPATITIS C VIRUS AMONG INDOOR AND OUTDOOR PATIENTS OF A TE...
SEROPREVALENCE OF HEPATITIS C VIRUS AMONG INDOOR AND OUTDOOR PATIENTS OF A TE...
 
Effects_ART_CD4_Count_Body_Weight_HIV_AIDS_Patients_Longitudinal_Analysis.pdf
Effects_ART_CD4_Count_Body_Weight_HIV_AIDS_Patients_Longitudinal_Analysis.pdfEffects_ART_CD4_Count_Body_Weight_HIV_AIDS_Patients_Longitudinal_Analysis.pdf
Effects_ART_CD4_Count_Body_Weight_HIV_AIDS_Patients_Longitudinal_Analysis.pdf
 
Detection of hepatitis b surface antigen (hbs ag) and hepatitis c
Detection of hepatitis b surface antigen (hbs ag) and hepatitis cDetection of hepatitis b surface antigen (hbs ag) and hepatitis c
Detection of hepatitis b surface antigen (hbs ag) and hepatitis c
 
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...
Clinical Features and Patterns of CD4+ T Lymphocyte Counts Among HIV/AIDS Pat...
 
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatiti...
 
study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...study of hematological paremeter in sepsis patients and its prognostic implic...
study of hematological paremeter in sepsis patients and its prognostic implic...
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Hep b & c in blood donors
Hep b & c in blood donorsHep b & c in blood donors
Hep b & c in blood donors
 
atypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptxatypical lymphocytes in dengue.pptx
atypical lymphocytes in dengue.pptx
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center
 
ic standards in blood banks case study.pdf
ic standards in blood banks case study.pdfic standards in blood banks case study.pdf
ic standards in blood banks case study.pdf
 
Seroprevalence of HBV infection
Seroprevalence of HBV infectionSeroprevalence of HBV infection
Seroprevalence of HBV infection
 
The relationship between the molecular epidemiology of hepatitis c and the be...
The relationship between the molecular epidemiology of hepatitis c and the be...The relationship between the molecular epidemiology of hepatitis c and the be...
The relationship between the molecular epidemiology of hepatitis c and the be...
 
Imjh april-2015-5
Imjh april-2015-5Imjh april-2015-5
Imjh april-2015-5
 
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...
Incidence of Tuberculosis in HIV Sero-positive Patients at HIV Clinic at Kamp...
 
CONFERENCE PROCEEDINGS(B3SC),September 2016,London
CONFERENCE PROCEEDINGS(B3SC),September 2016,LondonCONFERENCE PROCEEDINGS(B3SC),September 2016,London
CONFERENCE PROCEEDINGS(B3SC),September 2016,London
 

Outcome-of-Screening-Test-Performed-on-Volunteer-Blood-Donors-in-Chittagong-City

  • 1. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 1 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Outcome of Screening Test Performed on Volunteer Blood Donors in Chittagong City International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 Jashim MU1 , Sanjoy KD2 , Suhrawardy SM3 , Moynal H4 , Pranab C5 Abstract— Introduction: In Bangladesh every year about 270,000 units of blood need for transfusion. To meet such a big amount blood transfusion needs huge numbers of donors. According to WHO estimate, in Bangladesh every year found up to 16 million new infection with HBV, 5 million new infection with HCV and 160,000 new cases of HIV infection of effective screening of blood donors. This study aimed to determine the prevalence of infectious diseases among the Chittagong city, Bangladesh. Methods: This was a cross sectional study among 1500 volunteer blood donors in the Chittagong city from January, 2011 to September, 2011. Each donor was screened for Hepatitis B Virus, Hepatitis C virus, HIV, Malaria & Syphilis with Latex agglutination, immunochromatographic (ICT) test strip supplied by reagent manufacturer. Results: A total of 1500 volunteer blood donors with different age group and occupations volunteer participated in the study. 1320 were male and 180 were female with on professional blood donor. There are found total 33 positive cases in screening test of which HBsAg positive 21 cases (1.40%), anti-HIV positive 02 cases (0.13%), anti-HCV positive 02 cases (0.13%), RPR positive 07 cases (0.46%), Malaria positive 01 case (0.06%). Conclusion: This study proof that many apparently healthy blood donors are not safe donor, so screening test before blood or component of blood transfusion should be mandatory even for volunteer blood donor. Index Terms— Blood Donors, WHO, Bangladesh, Chittagong, Blood Transfusion, HIV, HBV, HCV, MP, RPR. ——————————  —————————— 1. Md. Jashim Uddin, Assistant Professor & HOD Department of Pathology, BGC Trust Medical College. 2. Sanjoy Kumar Dey, Assistant Professor Department of Neonatology, BSMMU, Shahbag, Dhaka. 3. S. M. Suhrawardy, Assistant Professor Department of Physiology, BGC Trust Medical College. 4. Moynal Hossain, Assistant Professor Department of Community Medicine, BGC Trust Medical College. 5. Pranab Chowdhury, Senior Lecturer Department of Pathology, BGC Trust Medical College.
  • 2. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 2 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Outcome of Screening Test Performed on Volunteer Blood Donors in Chittagong City International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 1. To find out percentages of volunteer blood donors infected with Hepatitis B Virus, Hepatitis C virus, HIV, Malaria & syphilis. 2. To find out relation of the volunteer blood donors infected with infectious diseases with occupation. 3. To explore percentages of Male & Female among the different screening test positive volunteer blood donors. 4. To identify percentage of different age group among the volunteer blood donors infected with infectious diseases. INTRODUCTION Blood transfusion history dates back about 200 years and is relatively recent considering the history of mankind. The credit of first successful human to human blood transfusion goes Dr. James Blundell, an obstetrician, who successfully transfused 8 oz (227 ml) of blood to a patient of post partum haemorrhage in 1818.2 The practice of Modern blood transfusion began in early twentieth century, about a hundred years back, with the discovery of the ABO blood group antibodies and antigens by Nobel Prize winner Karl Landsteiner, an Austrian physician in 1901 and Rh blood group antigens by Landsteiner and wiener in 1940. 2 According to WHO estimate the lack of effective screening of blood donor's results in up to 16 million new infections with HBV, 5 million new infections with HCV and 160,000 new cases of HIV infection every year. Incidences of transfusion mediated falciparum infected found in Bangladesh. 2 For many years WHO has been working to help nation to make the transfusion safe with following guidelines2: a. Establishment of a nationally coordinated blood transfusion service. b. Collection of blood only from voluntary donors. c. Testing of all blood for compatibility and TTIs and reduction of unnecessary transfusion. In Bangladesh every year about 270,000 units of blood need for transfusion. To meet such a big amount blood transfusion needs huge numbers of donors. Unfortunately it has been found that in this country professional blood donors are providing majority of the units of blood annually. A total of 1,687,390 donations under safe blood transfusion program mainly from voluntary donors were screened throughout the country during a period of 8 years (2001-2008). One hundred eleven donors (0.0065%) were found to be Positive for HIV. Overall HBsAg, anti-HCV and RPR was found positive in 0.96%, 0.15% and 0.15% donation respectively.2 So considering all above discussion it is found very important to screen all blood donations both voluntary and professional to prevent transfusion Mediated infectious diseases.
  • 3. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 3 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org METHODS & MATERIALS Method: -  Types of study- Descriptive cross sectional study.  Place of study- Chittagong City.  Period of study- January, 2011 to September, 2011.  Sample size/number of cases- 1500. Research Materials: -  Blood sample collected in pre-labeled pilot tubes, serum separated from clotted blood.  Sterile disposable plastic syringe.  Latex agglutination immunochromatographic (ICT) test strip to detect-  HBsAg  Anti- HCV  Anti- HIV  Anti treponema  Malaria  Leishman stained, Geimsa stained thin & thick blood film study for Malaria parasite.  Procedure of test- Tests performed according instruction supplied by reagent manufacturer. RESULTS Results are shown in the following diagrams and tables. Figure 1: Distribution of volunteer blood donors by sex Figure 2: Distribution of volunteer blood donors by age 88% 12% Distribution of volunteer blood donors by sex (n=1500) Male= 1320. Female= 180. 82 395 413 284 180 97 33 6 10 0 50 100 150 200 250 300 350 400 450 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55+ Distribution of volunteer blood donors by age (n=1500)
  • 4. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 4 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Figure 3: Distribution of blood donor according to occupation Figure 4: Percentage of disease among the total positive cases 0 100 200 300 400 500 600 Ser. Holder Student Housewife Business Driver Others Distribution of blood donor according to occupation (n=1500) 37.54% 18.33% 6.00% 31.20% 2.13% 4.80% 563 275 90 468 32 72 HBsAg(21) 63.64% HIV(02) 6.06% RPR(07) 21.21% HCV(02) 6.06% MP(01) 3.03% Percentage of disease among the total positive cases (n=33) HBsAg(21) HIV(02) RPR(07) HCV(02) MP(01)
  • 5. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 5 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Table 1: Distribution of volunteer blood donors by HBsAg Status Status of HBsAg Number Percentage Positive 21 1.40 % Negative 1479 98.60 % Total 1500 100 % Table 2: Distribution of volunteer blood donors by HIV Status Status of HIV Number Percentage Positive 02 0.13 % Negative 1498 99.87 % Total 1500 100 % Table 3: Distribution of volunteer blood donors by HCV Status Status of HCV Number Percentage Positive 02 0.13 % Negative 1498 99.87 % Total 1500 100 % Table 4: Distribution of volunteer blood donors by RPR Status Status of RPR Number Percentage Positive 07 0.46 % Negative 1493 99.54 % Total 1500 100 % Table 5: Distribution of volunteer blood donors by MP Status Status of MP Number Percentage Positive 01 0.06 % Negative 1499 99.94 % Total 1500 100 %
  • 6. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 6 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Table 6: Disease by Occupation (%) Occupation HBsAg HIV HCV RPR MP Service Holder 7 50/33.33 1 7.14/50 1 7.14/50 4 28.58/57.14 1 7.14/100 14 (100%) Student 4 100/19.05 0 0 0 0 4 (100%) Housewife 0 0 0 0 0 0 (100%) Business 8 72.73/38.10 0 1 9.09/50 2 18.18/28.57 0 11 (100%) Driver 2 66.66/9.52 0 0 1 33.34/14.29 0 3 (100%) Others 0 1 100/50 0 0 0 1 (100%) Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%) Table 7: Disease by Age (%) Age in year HBsAg HIV HCV RPR MP 15 - 19 1 100/4.77 0 0 0 0 1 (100%) 20 - 24 6 85.71/28.56 0 0 1 14.29/14.29 0 7 (100%) 25 - 29 9 81.82/42.85 0 1 9.09/50 0 1 9.09/100 11 (100%) 30 - 34 4 40/19.05 2 20/100 0 4 40/57.14 0 10 (100%) 35 - 39 1 50/4.77 0 1 50/50 0 0 2 (100%) 40 - 44 0 0 0 2 100/28.57 0 2 (100%) 45 - 49 0 0 0 0 0 0 (100%) 50 - 54 0 0 0 0 0 0 (100%) 55+ 0 0 0 0 0 0 (100%) Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%) Table 8: Disease by Sex (%) Sex HBsAg HIV HCV RPR MP Male 20 62.5/95.25 2 6.25/100 2 6.25/100 7 21.87/100 1 3.13/100 32 (100%) Female 01 100/4.75 0 0 0 0 1 (100%) Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%)
  • 7. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 7 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org Table 9: Disease by Blood Group (%) Blood Group HBsAg HIV HCV RPR MP A+ 6 75/28.57 0 0 1 12.5/14.29 1 12.5/100 8 (100%) B+ 7 53.85/33.33 1 7.69/50 1 7.69/50 4 30.77/57.14 0 13 (100%) AB+ 4 80/19.05 0 1 20/50 0 0 5 (100%) O+ 4 57.14/19.05 1 14.29/50 0 2 28.57/28.57 0 7 (100%) A- 0 0 0 0 0 0 (100%) B- 0 0 0 0 0 0 (100%) AB- 0 0 0 0 0 0 (100%) O- 0 0 0 0 0 0 (100%) Total 21 (100%) 2 (100%) 2 (100%) 7 (100%) 1 (100%) DISCUSSION In this study, total numbers of donors are 1500 among which there was no professional donor. Among them HBsAg positive was 21 cases (1.40%), anti-HIV positive 02cases (0.13%), anti-HCV positive 02 cases (0.13%), RPR (TP) positive 07 cases (0.46%), Malaria positive 01 case (0.06%). In a "Study on screening tests among the blood donors in Dhaka Medical College Hospital, Bangladesh" 1 done from January to December 2009 where out of 21,448 donors HBsAg positive were 297 (1.38%), anti-HCV positive 38 (0.10%), RPR (TP) positive 09 (0.40%), MP positive 23 (0.11%), 1 which are almost near to this study. In a another study "Incidence of common transfusion transmitted diseases among blood donors" 7 done in Khulna Medical College Hospital (KMCH) on 12,270 voluntary and directed donors during the period from 1st July 2007 to 30th June 2008 to see the incidence of HBV, HIV, HCV, Syphilis & MP, where it shows HBsAg positive were 171 (1.39%), anti-HIV positive 01 (0.008%), anti-HCV positive 03 (0.024%), none found positive for RPR (TP) and Malaria. 7 In our study found HBsAg positive were 21 cases (1.40%), anti-HIV positive 02 cases (0.13%), anti-HCV positive 02 cases (0.13%), RPR (TP) positive 07 cases (0.46%), Malaria positive 01 case (0.06%). Compare to this study Khulna Medical College Hospital (KMCH) study shows less numbers of HIV positive, no positive cases of RPR (TP) and Malaria. Probably because of geographical different, professional different as of Chittagong are more overseas worker & Chittagong is a Malaria zone too, period of study and prevalence of unsafe sex & I.V. drug abusers should consider because all those are increasing now a days. One study in Nigeria "Sexual transmission of the hepatitis B virus among blood donors in a tertiary hospital in Nigeria" 9 done are 234 blood donors aged 18 to 56 years (mean 27.3 years) shows 40 (17.1%) participants found positive and 194 (82.9%) negative for HBsAg. 9 In our study it is found only 21 (1.40%) cases positive for HBsAg among 1500 cases. This big different of HBsAg positive probably because of religious conservations, more safe sex and less I.V. drug abusers in Bangladesh.
  • 8. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 8 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org One study in Philippines "The prevalence of HBsAg(+) and anti-HCV(+) among healthy blood donors at EAMC, Quezon City" 6 done in 6,560 healthy blood donors from December 1, 2003 to November 30, 2004 at East Avenue Medical Center among which 503 (7.67%) donors are HBsAg positive. There were only 07 (0.12%) donors who tested positive for anti-HCV among 6,057 cases of the donors.6 & another in Turkey "The prevalence of HBV, HCV and HIV infection among donor in Ijmer, Turkey" 5 HBV positive (1.38%) and HCV positive (0.35%).5 In our study HBsAg positive was 21 cases (1.40%) & anti-HCV positive 02 cases (0.13%).In a study in Canada "Incidence of HBV, HCV and HIV in Canada" 4 which were HBsAg positive is (12.40%), HIV positive (0.38%) and HCV positive (16.83%). 4 In our study, HBsAg positive was 21 cases (1.40%), anti-HIV positive 02 cases (0.13%) & anti-HCV positive 02 cases (0.13%). In Bombay, HBsAg positive in 06% and in Pakistan it is 05%. 3 In our study, HBsAg positive was 1.40%. In another study done by "Safe blood transfusion center, Annual reports of donor screening, DMCH, Dhaka"8 in 2009 which were HBsAg positive (0.96%), HIV positive (0.0065%), HCV positive (0.15%) & RPR (TP) positive (0.15%). 8 In our study HBsAg positive was (1.40%), anti- HIV positive (0.13%), anti-HCV (0.13%), RPR (TP) positive (0.46%). CONCLUSION In this study it has been found that out of 1500 volunteer blood donors 33 persons are screening positive who are apparently healthy but they don’t has any knowledge that they are infected by these sort of transmissible infective dangerous disease which can cause 1. Serious complication to the affected individuals as they would not seek medical care as long as they remain asymptomatic. 2. Easy transmission to other healthy people because of lacking of preventive measure because the affected individuals and his surrounding peoples, family members are not aware about the condition. This study proof that many apparently healthy blood donors are not safe donor, so screening test before blood or component of blood transfusion should be mandatory even for volunteer blood donor. SUGGESTION Increasing level of consciousness about transmission of transmissible disease by counseling about blood & blood component transfusion, multiple uses of needles, safe sex etc. Assuring use of sterile surgical instruments, syringe, using gloves by medical staff. Government, NGO should come forward make the screening test available & chipper.
  • 9. International Journal of Scientific & Engineering Research Volume 3, Issue 12, December-2012 9 ISSN 2229-5518 IJSER © 2012 http://www.ijser.org ACKNOWLEDGEMENT Special thanks to "Sheik Md. Morshedul Alam Chy" Technologist (Agrani Pathology Laboratory, Banadrtila, Chittagong-4218, Bangladesh) for his cordial help for the study. REFERENCES 1. Chowdhury FS, Begum HA, Adnan SD, Hoque MM, Hossain MZ, Siddiqui MAE, et al. Study on screening tests among the blood donors in DMCH, Bangladesh. J Dhaka Medcoll. 2010; 19(1): 16-18. 2. Mahmud Z, et al. Are the blood transfusions safe! JAFMC Bangladesh. Vol 5, No 1 (June) 2009. 3. Rahman K, Khan AA, Huda Z, et al. Prevalence of seromarkers of HBV and HCV in health care personal and apparently healthy blood donors. J Pak Med Assoc. 46: 152-4. 4. Chiavetta JA, Escobar M, et al. Incidence of HBV, HCV and HIV in Canada, CMAJ. 2003; 169(8). 5. The prevalence of HBV, HCV and HIV infection among donor in Ijmer, Turkey. Indian J Med Microbiol. 26(3). 6. John G Rodenas, Laura C Bacasen, Ernesto R Que, et al. The prevalence of HBsAg(+) and anti-HCV(+) among healthy blood donors at EAMC, Quezon City. Phil J of Gastroenterology 2006; 2:64:70. 7. Ahmed MU, Begum HA, Hossain T, Chakraborty P, et al. Incidence of common transfusion transmitted diseases among blood donors. JAFMC Bangladesh. Vol 5, No 1 (June) 2009. 8. Safe blood transfusion center. Annual reports of donor screening, DMCH, Dhaka. 2009. 9. Adekanle O, Ndububa DA, Ayodeji OO, Paul-Odo B, Folorunso TA, et al. Sexual transmission of the hepatitis B virus among blood donors in a tertiary hospital in Nigeria. Singapore Med J 2010; 51(12): 944.